Global Brain Haemorrhage Treatment Market to Grow 6.1% Annually to 2017

March 22, 2011 - PRLog -- ‘Hemorrhage Therapy Area Pipeline Report’ now available at: http://www.pharmaceutical-market-research.com/go/LSA19313 contains detailed information on the haemorrhage drug pipeline. This report provides insight into the pipeline status of haemorrhage drugs by company and by stage as well as a summary of the latest news and developments in this area.

The global brain haemorrhage market was valued at $540m in 2009 and forecasts it to grow at a CAGR)of 6.1% to reach $868m by 2017. This modest growth forecast is primarily attributed to a weak pipeline landscape. The existing market is weak due to lack of targeted therapies, poor awareness levels of the condition and the poor safety profiles of the existing therapies. The market is characterised by several off-label drugs and generics that treat the symptoms of the condition. Antihypertensive agents, antiepileptic agents, stool softeners, antidotes and analgesics are the most commonly employed therapies to treat the condition symptomatically.

Product ID: LSA19313

About:  http://www.pharmaceutical-market-research.com/publication... is the source for information products concerning the global biotechnology, healthcare, medical device and pharmaceutical industries. With over 20,000 market reports available, executives can find a current and comprehensive range of specialised intelligence. www.pharmaceutical-market-research.com is a service from Piribo Ltd, which was founded in 2004.

# # #

About Piribo.
Piribo http:www.piribo.com is the source for information products concerning the global biotechnology and pharmaceutical industries. Here you can browse and buy thousands of business information studies, market reports and books.